Organization
Daewon Pharmaceutical
3 clinical trials
Clinical trial
Phase III Clinical Trial to Evaluate the Efficacy and Safety of DWKHStatus: Completed, Estimated PCD: 2022-12-09
Clinical trial
A Randomized, Double Blind, Parallel, Multi-center, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A in Patient With Primary Hypercholesterolemia or Mixed DyslipidemiaStatus: Completed, Estimated PCD: 2023-04-13
Clinical trial
A Bioequivalence Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety After Administration of DW5221 and DW5221-R in Healthy Adult Male VolunteersStatus: Completed, Estimated PCD: 2022-10-26